Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 2
2004 3
2005 11
2006 15
2007 12
2008 15
2009 7
2010 3
2011 5
2012 8
2013 8
2014 6
2015 11
2016 13
2017 13
2018 8
2019 10
2020 10
2021 7
2022 5
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Muniz M, Loprinzi CL, Orme JJ, Koch RM, Mahmoud AM, Kase AM, Riaz IB, Andrews JR, Thorpe MP, Johnson GB, Kendi AT, Kwon ED, Nauseef JT, Morgans AK, Sartor O, Childs DS. Muniz M, et al. Among authors: kwon ed. Cancer Treat Rev. 2024 Apr 30;127:102748. doi: 10.1016/j.ctrv.2024.102748. Online ahead of print. Cancer Treat Rev. 2024. PMID: 38703593 Review.
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients.
Dasari S, McCarthy MR, Wojcik AA, Pitel BA, Samaddar A, Tekin B, Whaley RD, Raghunathan A, Hernandez LH, Jimenez RE, Stish BJ, Thompson RH, Leibovich BC, Boorjian SA, Jeffrey Karnes R, Childs DS, Quevedo JF, Kwon ED, Pagliaro LC, Costello BA, Halling KC, Cheville JC, Kipp BR, Gupta S. Dasari S, et al. Among authors: kwon ed. Prostate Cancer Prostatic Dis. 2024 Feb 27. doi: 10.1038/s41391-024-00814-2. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38413763
Low PSA radiographic disease progression on C11-choline PET.
Mahmoud AM, Ahmed ME, Kendi AT, Thorpe M, Johnson GB, Riaz IB, Orme JJ, Kwon ED, Andrews JR, Childs DS. Mahmoud AM, et al. Among authors: kwon ed. BJUI Compass. 2023 Oct 25;5(2):319-324. doi: 10.1002/bco2.308. eCollection 2024 Mar. BJUI Compass. 2023. PMID: 38371200 Free PMC article.
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer.
Ahmed ME, Lee MS, Mahmoud AM, Joshi VB, Gopalakrishna A, Bole R, Haloi R, Kendi AT, Bold MS, Bryce AH, Karnes RJ, Kwon ED, Childs DS, Andrews JR. Ahmed ME, et al. Among authors: kwon ed. Prostate Cancer Prostatic Dis. 2023 Nov 7. doi: 10.1038/s41391-023-00751-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37935879
154 results